Alamandine reduces eosinophilic inflammation in an experimental model of asthma
J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil)
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1648
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil). Alamandine reduces eosinophilic inflammation in an experimental model of asthma. 1648
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: